Percutaneous Mechanical Circulatory Support Devices Market

Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.

Percutaneous Mechanical Circulatory Support Devices Market contains market size and forecasts of Percutaneous Mechanical Circulatory Support Devices in global, including the following market information:

• Global Percutaneous Mechanical Circulatory Support Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Percutaneous Mechanical Circulatory Support Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Percutaneous Mechanical Circulatory Support Devices companies in 2021 (%)

The global Percutaneous Mechanical Circulatory Support Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Extracorporeal Membrane Oxygenation Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Percutaneous Mechanical Circulatory Support Devices include Medtronic, Abbott Laboratories, LivaNova, Eurosets, Jarvik Heart, Cardiobridge, Getinge AB, ABIOMED and Teleflex Incorporated and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Percutaneous Mechanical Circulatory Support Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Percutaneous Mechanical Circulatory Support Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Percutaneous Mechanical Circulatory Support Devices Market Segment Percentages, by Type, 2021 (%)

• Extracorporeal Membrane Oxygenation Device
• Extracorporeal Ventricular Assist Device
• Others

Global Percutaneous Mechanical Circulatory Support Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Percutaneous Mechanical Circulatory Support Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialized Cardiac Centers
• Ambulatory Surgery centers
• Others

Global Percutaneous Mechanical Circulatory Support Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Percutaneous Mechanical Circulatory Support Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Percutaneous Mechanical Circulatory Support Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Percutaneous Mechanical Circulatory Support Devices revenues share in global market, 2021 (%)
• Key companies Percutaneous Mechanical Circulatory Support Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Percutaneous Mechanical Circulatory Support Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• Abbott Laboratories
• LivaNova
• Eurosets
• Jarvik Heart
• Cardiobridge
• Getinge AB
• ABIOMED
• Teleflex Incorporated
• Berlin Heart